28.88
price down icon0.69%   -0.21
 
loading

Alkermes Plc 주식(ALKS)의 최신 뉴스

pulisher
Jun 18, 2025

Alkermes (ALKS) Upgraded by UBS with Positive Development Prospe - GuruFocus

Jun 18, 2025
pulisher
Jun 17, 2025

Alkermes stock upgraded at UBS on sleep disorder drug (ALKS) - Seeking Alpha

Jun 17, 2025
pulisher
Jun 17, 2025

Alkermes Gains Momentum With Promising Narcolepsy Drug - Finimize

Jun 17, 2025
pulisher
Jun 17, 2025

Alkermes' ALKS-2680 Seen as Potential Breakthrough for Narcolepsy, Hypersomnia, BofA Says - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Alkermes (ALKS) Gains Upgrade from UBS with Positive Outlook | A - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Alkermes (ALKS) Gains Upgrade from UBS with Positive Outlook | ALKS Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Nvidia To Rally More Than 38%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

Jun 17, 2025
pulisher
Jun 17, 2025

Alkermes (ALKS) Receives Buy Rating Upgrade from UBS | ALKS Stoc - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

This Cooper Companies Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday - Benzinga

Jun 17, 2025
pulisher
Jun 17, 2025

Alkermes (ALKS) Receives Buy Rating Upgrade from UBS | ALKS Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) - Benzinga

Jun 17, 2025
pulisher
Jun 17, 2025

UBS Upgrades Alkermes Public to Buy From Neutral, Adjusts Price Target to $42 From $33 - marketscreener.com

Jun 17, 2025
pulisher
Jun 17, 2025

Alkermes (ALKS) Receives Upgrade as Prospects Brighten for Narco - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Alkermes (ALKS) Receives Upgrade as Prospects Brighten for Narcolepsy Treatment | ALKS Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 12, 2025

When (ALKS) Moves Investors should Listen - news.stocktradersdaily.com

Jun 12, 2025
pulisher
Jun 12, 2025

Substance Abuse Treatment Market Size, Trends & Growth - openPR.com

Jun 12, 2025
pulisher
Jun 10, 2025

Insider Sell: Christian Nichols Sells Shares of Alkermes PLC - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

RBC Capital maintains Alkermes stock rating amid safety concerns By Investing.com - Investing.com Nigeria

Jun 10, 2025
pulisher
Jun 10, 2025

GAMMA Investing LLC Grows Position in Alkermes plc (NASDAQ:ALKS) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Transcript : Alkermes plc Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 10 - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Alkermes at Goldman Sachs Healthcare: Strategic Moves in Sleep Disorders By Investing.com - Investing.com Nigeria

Jun 09, 2025
pulisher
Jun 09, 2025

Alkermes at Goldman Sachs Healthcare: Strategic Moves in Sleep Disorders - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Alkermes To Present At Goldman Sachs Global Conference; Webcast At 10:00 AM ET - Nasdaq

Jun 09, 2025
pulisher
Jun 06, 2025

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Alkermes plc To Contact The Firm - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 06, 2025

Fed. Circ. Weighs Purview Over Acorda's $17M Arbitral Award - Law360

Jun 06, 2025
pulisher
Jun 05, 2025

Substance Abuse Treatment Market Set to Witness Digital and Personalized Care Expansion | Indivior, Alkermes - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

Controlled Release Drug Delivery Market Is Booming So Rapidly - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

Nanotechnology Drug Delivery Market Set to Witness Significant - openPR.com

Jun 05, 2025
pulisher
Jun 04, 2025

Alkermes plc (NASDAQ:ALKS) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences - The Malaysian Reserve

Jun 03, 2025
pulisher
Jun 02, 2025

Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference - StreetInsider

Jun 02, 2025
pulisher
Jun 02, 2025

Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference | ALKS Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Opioid Use Disorder Market Projected to Witness Massive GrowthIndivior PLC, Alkermes plc - openPR.com

Jun 02, 2025
pulisher
May 31, 2025

Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 48% Undervaluation? - simplywall.st

May 31, 2025
pulisher
May 31, 2025

Where are the Opportunities in (ALKS) - news.stocktradersdaily.com

May 31, 2025
pulisher
May 31, 2025

Cetera Investment Advisers Increases Stock Position in Alkermes plc (NASDAQ:ALKS) - Defense World

May 31, 2025
pulisher
May 29, 2025

Alkermes (ALKS) to Present New Findings on ALKS 2680 at SLEEP 20 - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Alkermes (ALKS) to Present New Findings on ALKS 2680 at SLEEP 2025 | ALKS Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Alkermes to Present New Research Related to ALKS 2680 at SLEEP 2025 - goSkagit

May 29, 2025
pulisher
May 29, 2025

Global Healthcare & Medical Tourism News - Medical Tourism Magazine

May 29, 2025
pulisher
May 28, 2025

This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

May 28, 2025
pulisher
May 28, 2025

Needham's Positive Outlook on Alkermes (ALKS) with Promising Sal - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Needham Initiates Alkermes Public at Buy With $45 Price Target - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Needham Initiates Coverage on Alkermes (ALKS) with Buy Rating | ALKS Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Needham's Positive Outlook on Alkermes (ALKS) with Promising Sales Projections | ALKS Stock News - GuruFocus

May 28, 2025
pulisher
May 27, 2025

Quantinno Capital Management LP Acquires New Position in Alkermes plc (NASDAQ:ALKS) - Defense World

May 27, 2025
pulisher
May 23, 2025

Controlled Release Drug Delivery Market Generated - openPR.com

May 23, 2025
pulisher
May 23, 2025

Bank of America Corp DE Trims Stake in Alkermes plc (NASDAQ:ALKS) - Defense World

May 23, 2025
pulisher
May 21, 2025

Alkermes Shareholders Approve Amendments at Annual Meeting - TipRanks

May 21, 2025
pulisher
May 20, 2025

(ALKS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 20, 2025
pulisher
May 20, 2025

Alkermes price target raised to $35 from $34 at BofA - MSN

May 20, 2025
pulisher
May 19, 2025

Captrust Financial Advisors Raises Stock Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World

May 19, 2025
pulisher
May 16, 2025

Nanotechnology Drug Delivery Market Generated Opportunities, - openPR.com

May 16, 2025
$13.39
price down icon 0.52%
$8.855
price down icon 0.23%
$127.12
price up icon 0.43%
$292.31
price up icon 0.67%
drug_manufacturers_specialty_generic RDY
$15.28
price up icon 0.23%
$16.91
price down icon 0.53%
자본화:     |  볼륨(24시간):